JPY 174.0
(0.58%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -2 Million JPY | -276.79% |
2022 | -616 Million JPY | 3623.53% |
2021 | 116 Million JPY | -103.31% |
2020 | -278 Million JPY | -15.46% |
2019 | 683 Million JPY | 439.66% |
2018 | -133 Million JPY | 32.96% |
2017 | -271 Million JPY | -186.61% |
2016 | -304 Million JPY | 199.09% |
2015 | -383.63 Million JPY | 48.09% |
2014 | -681.76 Million JPY | -41.78% |
2013 | -493.9 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1 Million JPY | 2583.33% |
2023 Q3 | -175 Million JPY | 78.29% |
2023 FY | - JPY | -276.79% |
2023 Q1 | 221 Million JPY | -10.16% |
2023 Q4 | -668 Million JPY | -281.71% |
2023 Q2 | -806 Million JPY | -464.71% |
2022 FY | - JPY | 3623.53% |
2022 Q3 | -164 Million JPY | -1193.33% |
2022 Q4 | 246 Million JPY | 250.0% |
2022 Q2 | 15 Million JPY | -97.04% |
2022 Q1 | 506 Million JPY | 79.43% |
2021 Q4 | 282 Million JPY | 554.84% |
2021 Q2 | -62 Million JPY | 64.57% |
2021 Q3 | -62 Million JPY | 0.0% |
2021 FY | - JPY | -103.31% |
2021 Q1 | -175 Million JPY | -257.66% |
2020 FY | - JPY | -15.46% |
2020 Q3 | -23 Million JPY | -104.65% |
2020 Q1 | -67 Million JPY | -123.33% |
2020 Q2 | 495 Million JPY | 838.81% |
2020 Q4 | 111 Million JPY | 582.61% |
2019 Q4 | -30 Million JPY | -109.17% |
2019 Q2 | -77 Million JPY | -119.85% |
2019 Q1 | 388 Million JPY | 227.21% |
2019 FY | - JPY | 439.66% |
2019 Q3 | 327 Million JPY | 524.68% |
2018 Q2 | 54 Million JPY | 156.25% |
2018 Q3 | 167 Million JPY | 209.26% |
2018 Q4 | -305 Million JPY | -282.63% |
2018 FY | - JPY | 32.96% |
2018 Q1 | -96 Million JPY | -43.92% |
2017 Q1 | -165.78 Million JPY | -32.87% |
2017 FY | - JPY | -186.61% |
2017 Q4 | -66.7 Million JPY | -373.03% |
2017 Q3 | 24.43 Million JPY | 225.73% |
2017 Q2 | -19.43 Million JPY | 88.28% |
2016 Q2 | 552.69 Million JPY | 274.85% |
2016 Q4 | -124.77 Million JPY | 13.79% |
2016 Q3 | -144.72 Million JPY | -126.19% |
2016 Q1 | -316.09 Million JPY | -171.53% |
2016 FY | - JPY | 199.09% |
2015 FY | - JPY | 48.09% |
2015 Q4 | -116.41 Million JPY | 30.14% |
2015 Q3 | -166.64 Million JPY | -56.15% |
2015 Q2 | -106.71 Million JPY | 58.63% |
2015 Q1 | -257.96 Million JPY | -95.57% |
2014 Q3 | -309.47 Million JPY | -70.91% |
2014 Q1 | -186 Million JPY | -16.54% |
2014 FY | - JPY | -41.78% |
2014 Q4 | -131.9 Million JPY | 57.38% |
2014 Q2 | -181.08 Million JPY | 2.65% |
2013 FY | - JPY | 0.0% |
2013 Q4 | -159.61 Million JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
DVx Inc. | 807.98 Million JPY | 100.248% |
Seikagaku Corporation | 2.09 Billion JPY | 100.095% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 100.035% |
Create Medic Co., Ltd. | 1.39 Billion JPY | 100.144% |
PHC Holdings Corporation | 39.08 Billion JPY | 100.005% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | 100.102% |
Rion Co., Ltd. | 4.37 Billion JPY | 100.046% |
Nihon Kohden Corporation | 23.44 Billion JPY | 100.009% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 100.006% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 100.016% |
Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | 100.061% |
3-D Matrix, Ltd. | 2.09 Billion JPY | 100.096% |